Cynthia Schwalm has spent her entire career in the healthcare industry. Prior to joining in February 2014, she held a variety of COO roles for various biotech and specialty companies.
Cynthia Schwalm has over 30 years of senior healthcare experience in the fields of pharmaceuticals, biotechnology and medical devices.
As President of Ipsen North America, she leads all commercial operations for the U.S. and Canada, and manages shared services for Ipsen research facility in Cambridge, MA. Previously, she served as Chief Operating Officer of Eisai Inc. She joined Eisai in 2008 from Amgen Inc. where she served as a Vice President and General Manager of the Oncology Business Unit of Amgen Inc. since May 2005.
Cynthia started her corporate career at Johnson and Johnson (J&J) with Janssen Pharmaceutica, a division of J&J, where she held multiple commercial roles over an eighteen year period, including her role as General Manager of Ortho Biotech UK & Ireland, a J&J biotech company.
Cynthia currently serves on the Harvard JFK School Women’s Leadership Board.
Cynthia is a graduate of the Executive MBA program at the Wharton School of Business, University of Pennsylvania. Her undergraduate degree, a Bachelor of Science in Nursing, was completed at the University of Delaware.